Literature DB >> 19437314

The prevalence of lens opacities in Tehran: the Tehran Eye Study.

Hassan Hashemi1, Elham Hatef, Akbar Fotouhi, Ali Feizzadeh, Kazem Mohammad.   

Abstract

PURPOSE: To determine the prevalence of lens opacities and cataract surgical coverage among Tehran citizens 40 years of age and older.
METHODS: The Tehran Eye Study was a population-based survey, with random sampling from Tehran household clusters. Those 40 years of age and older from that survey were included in this analysis. All participants underwent full optometric, slit lamp, and fundoscopic examinations. Lens opacity was assessed after pupil dilation using the modified Lens Opacities Classification System III (LOCS III). The main indices for prevalence of cataract were any lens changes, defined as the presence of a gradable cataract in one or both eyes, and all lens changes, defined as any lens changes plus a history of cataract surgery.
RESULTS: A total of 1434 participants were included in this analysis; 305 of which met the criteria for all lens changes resulting in an adjusted prevalence of 22.7% (CI95%: 20.2%-25.3%). The prevalence was 21.2% among men and 24.5% among women. The prevalence of any lens changes was 19.1% (CI95%: 16.6%-21.6%) and the prevalence was higher in women. The prevalence for both indices increased with age. Considering their better eyes, 39 people (2.7%) were shown to have low vision because of cataract and another 12 (0.8%) were classified as blind.
CONCLUSIONS: Cataract has affected approximately one-fifth of the Tehran population aged 40 years and over, women more than men, and has severely affected the vision of approximately 3.5% of this population. We found that access to cataract surgery facilities was not an issue.

Entities:  

Mesh:

Year:  2009        PMID: 19437314     DOI: 10.1080/09286580902863031

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  7 in total

1.  The gender issue in congenital and developmental cataract surgery.

Authors:  Marzieh Katibeh; Armen Eskandari; Mehdi Yaseri; Sara Hosseini; Hossein Ziaei
Journal:  J Ophthalmic Vis Res       Date:  2013-10

Review 2.  Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis.

Authors:  Hassan Hashemi; Reza Pakzad; Abbasali Yekta; Mohamadreza Aghamirsalim; Mojgan Pakbin; Shahroukh Ramin; Mehdi Khabazkhoob
Journal:  Eye (Lond)       Date:  2020-02-13       Impact factor: 3.775

3.  The association between refractive errors and cataract: the tehran eye study.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Mohammad Miraftab; Kazem Mohammad; Akbar Fotouhi
Journal:  Middle East Afr J Ophthalmol       Date:  2011-04

4.  Trend in cataract surgical rate in iran provinces.

Authors:  Hassan Hashemi; Farhad Rezvan; Mehdi Khabazkhoob; Hamidreza Gilasi; Koroush Etemad; Alireza Mahdavi; Soheila Asgari
Journal:  Iran J Public Health       Date:  2014-07       Impact factor: 1.429

5.  Customized Clinical Practice Guidelines for Management of Adult Cataract in Iran.

Authors:  Zhaleh Rajavi; Mohammad Ali Javadi; Narsis Daftarian; Sare Safi; Farhad Nejat; Armin Shirvani; Hamid Ahmadieh; Saeid Shahraz; Hossein Ziaei; Hamidreza Moein; Behzad Fallahi Motlagh; Sepehr Feizi; Alireza Foroutan; Hassan Hashemi; Seyed Javad Hashemian; Mahmoud Jabbarvand; Mohammad Reza Jafarinasab; Farid Karimian; Hossein Mohammad-Rabei; Mehrdad Mohammadpour; Nader Nassiri; Mahmoodreza Panahi-Bazaz; Mohammad Reza Rohani; Mohammad Reza Sedaghat; Kourosh Sheibani
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

6.  Eye disorders in old people.

Authors:  Mohammad Khalaj; Ameneh Barikani; Hafez Ghasemi
Journal:  Glob J Health Sci       Date:  2012-11-06

7.  Cataract Surgical Rate between 2006 and 2010 in Tehran Province.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Farhad Rezvan; Koroush Etemad; Hamidreza Gilasi; Soheila Asgari; Alireza Mahdavi; Sara Soroush; Abbasali Yekta; Akbar Fotouhi
Journal:  Iran J Public Health       Date:  2015-09       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.